R2D2 Program for Type 1 Diabetes Distress
Remedy to Diabetes Distress (R2D2): A Scalable Screen to Treat Program for School-age Families
Recruiting
N/A
Interventional Study
Type 1 Diabetes
No Placebo Group
Every participant receives an active treatment — no one gets a placebo.
At a Glance
- Age
- 8 – 65
- Sex
- Any
- Study type
- Interventional
- Purpose
- Treatment
- Participants needed
- 180 (estimated)
- Sponsor
- Nemours Children's Clinic · Other
Who this trial is looking for
This trial is looking for families with children aged 8 to 12 who have type 1 diabetes and experience diabetes distress. Participants will join a program aimed at helping reduce this distress to improve their child's blood sugar control.
Are You a Good Fit for This Trial?
You may be able to join if
- I am between 8 and 12 years old.
- I have been diagnosed with type 1 diabetes.
- My child or I, or both of us, report high levels of diabetes distress.
- My child is on an intensive insulin regimen.
You may not be able to join if
- My child is on a conventional insulin regimen.
- We do not report high levels of diabetes distress.
- My child has an allergy or sensitivity to the adhesive used for CGM.
- My child has another chronic condition.
- We do not speak English.
Summarized in plain language from this trial's official eligibility criteria. The full criteria are further down this page — only the research team can confirm whether you qualify.
Think this trial could be right for you?
Answer three quick questions written from this study's own rules to see if you may qualify. No account needed to find out.
Check Your Eligibility
About This Trial
This R01 is in response to RFA-DK-19-021, Treating Diabetes Distress to Improve Glycemic Outcomes in Type 1 Diabetes. The objective is to test the feasibility and acceptability of a novel, practical, and potentially scalable screen to treat program for diabetes distress in families of school-age children with T1D (called Remedy to Diabetes Distress \[R2D2\]) and to test the initial efficacy of R2D…
Trial Locations
Loading…
Loading trial locations…
Eligibility Criteria
Inclusion Criteria:
* child age between 8-12 years, physician confirmed T1D diagnosis,
* either the child or the parent or both the child and parent report diabetes distress levels at or above clinical cut-points,
* child is on an intensive insulin regimen (pump or MDI).
Exclusion Criteria:
* chi…
Contacts